Format

Send to

Choose Destination
See comment in PubMed Commons below
Mol Biol Rep. 2012 Sep;39(9):8813-9. doi: 10.1007/s11033-012-1744-3. Epub 2012 Jun 22.

NAT2 polymorphisms with oral carcinoma susceptibility: a meta-analysis.

Author information

1
Department of Stomatology, Xinqiao Hospital, Third Military Medical University, Chongqing, China.

Abstract

Published data have implicated NAT2 polymorphisms as risk factors for various cancers. A number of studies have focused on the association of NAT2 polymorphisms with susceptibility to oral carcinoma and have yielded inconclusive results. The aim of the present study was to derive a more precise estimation of the relationship. We first carried out a deliberate search in the databases without a language limitation, covering all papers published up to Dec 2011. A total of seven case-control studies including 1,379 cases and 1,868 controls were selected and the relevant data were extracted for systematic meta-analyses. No significant association was found for the overall data (OR: 1.04, 95 % CI: 0.79-1.39). In subgroup analyses according to ethnicity, slow acetylators might increase oral cancer risk among Asians (OR: 1.38, 95 % CI: 1.04-1.82) but not Caucasians or Mixed races. The data suggested that NAT2 polymorphisms might be a low-penetrant risk factor for oral carcinoma in Asians.

PMID:
22722991
DOI:
10.1007/s11033-012-1744-3
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Springer
    Loading ...
    Support Center